NEPHROS INC's ticker is NEPH and the CUSIP is 640671400. A total of 17 filers reported holding NEPHROS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,457,408 | -3.7% | 3,687,438 | +0.8% | 1.21% | +7.3% |
| Q2 2023 | $5,669,071 | +44.9% | 3,657,465 | 0.0% | 1.13% | +39.0% |
| Q1 2023 | $3,913,471 | -7.7% | 3,657,465 | 0.0% | 0.81% | -7.1% |
| Q4 2022 | $4,239,462 | +27.3% | 3,657,465 | 0.0% | 0.87% | -17.2% |
| Q3 2022 | $3,329,000 | -98.1% | 3,657,465 | +0.1% | 1.05% | -89.4% |
| Q2 2022 | $174,670,000 | -67.3% | 3,655,111 | -0.2% | 9.98% | -63.0% |
| Q1 2022 | $533,734,000 | -17.4% | 3,663,969 | +0.4% | 26.94% | -0.2% |
| Q4 2021 | $646,532,000 | +1654.4% | 3,650,529 | +0.5% | 26.99% | +386.1% |
| Q2 2021 | $36,852,000 | +55.5% | 3,631,197 | +1.9% | 5.55% | +56.8% |
| Q1 2021 | $23,704,000 | -22.4% | 3,564,530 | +0.1% | 3.54% | -26.0% |
| Q4 2020 | $30,564,000 | +24.5% | 3,562,246 | +4.9% | 4.79% | -27.2% |
| Q3 2020 | $24,550,000 | -13.8% | 3,395,579 | 0.0% | 6.57% | -8.2% |
| Q2 2020 | $28,489,000 | +33.2% | 3,395,579 | 0.0% | 7.16% | -9.5% |
| Q1 2020 | $21,391,000 | – | 3,395,579 | – | 7.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEXFORD CAPITAL LP | 3,395,579 | $21,391,000 | 7.91% |
| BARD ASSOCIATES INC | 207,569 | $2,640,000 | 1.94% |
| Parkman Healthcare Partners LLC | 251,366 | $1,584,000 | 0.73% |
| Cowen Prime Services LLC | 154,800 | $975,000 | 0.60% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 12,957 | $82,000 | 0.07% |
| INGALLS & SNYDER LLC | 133,140 | $839,000 | 0.06% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 39,863 | $251,000 | 0.05% |
| B. Riley Wealth Advisors, Inc. | 14,428 | $91,000 | 0.01% |
| HighTower Advisors, LLC | 43,210 | $273,000 | 0.00% |
| BLAIR WILLIAM & CO/IL | 34,249 | $216,000 | 0.00% |